Product Code: ETC13175585 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pancreatic and Biliary Stents Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 1.9 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The global pancreatic and biliary stents market is witnessing steady growth attributed to the increasing prevalence of pancreatic and biliary diseases, such as pancreatic cancer, biliary obstruction, and pancreatitis. These stents are used to maintain the patency of the ducts and facilitate the flow of fluids, bile, or pancreatic juices. Technological advancements in stent design, such as the development of fully covered self-expandable metal stents (FCSEMS) and drug-eluting stents, are driving market growth. Additionally, the rising adoption of minimally invasive procedures and the growing aging population prone to these diseases are further boosting market demand. Key players in the market include Boston Scientific Corporation, Cook Medical, Medtronic, and C.R. Bard. The market is expected to continue growing as the incidence of pancreatic and biliary diseases increases globally.
The Global Pancreatic and Biliary Stents Market is witnessing a growing demand due to the increasing prevalence of pancreatic and biliary diseases, such as pancreatitis, gallstones, and bile duct obstructions. Key trends in the market include the development of advanced stent designs with improved biocompatibility and durability, as well as the rising adoption of minimally invasive procedures for stent placement. Opportunities in the market are driven by technological advancements, such as the use of drug-eluting stents for targeted drug delivery, and the expanding applications of stents in the treatment of various gastrointestinal disorders. Additionally, the market is benefiting from the increasing geriatric population and the rising awareness among healthcare providers regarding the benefits of stent therapy in improving patient outcomes and reducing hospital stays.
The Global Pancreatic and Biliary Stents Market faces several challenges, including the high cost of stents, stringent regulations for product approval, and the risk of complications such as stent migration or occlusion. Additionally, the market is highly competitive with numerous players offering similar products, leading to pricing pressure and reduced profit margins. Limited awareness about the benefits of pancreatic and biliary stents among patients and healthcare providers also hinders market growth. Moreover, the prevalence of alternative treatment options, such as surgery or medication, presents a challenge in convincing healthcare professionals to adopt stent placement as a preferred treatment method. Overall, addressing these challenges will require companies to focus on innovation, cost-effective solutions, and targeted marketing strategies to drive market expansion.
The Global Pancreatic and Biliary Stents Market is primarily being driven by the increasing prevalence of pancreatic and biliary diseases such as pancreatitis, gallstones, and bile duct cancer. The rising aging population, unhealthy lifestyle choices leading to higher incidences of these diseases, and advancements in stent technology are also contributing to market growth. Additionally, the growing adoption of minimally invasive procedures for the treatment of pancreatic and biliary disorders, along with the rising demand for stents with better efficacy and reduced complications, are key drivers shaping the market. Furthermore, the expanding healthcare infrastructure in emerging economies and the increasing awareness about early diagnosis and treatment of these conditions are expected to further propel the market for pancreatic and biliary stents in the coming years.
Government policies related to the Global Pancreatic and Biliary Stents Market focus on regulating the safety and efficacy of medical devices to protect patient health. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU require manufacturers to adhere to strict guidelines for product approval and post-market surveillance. These policies aim to ensure quality standards, promote innovation, and safeguard patient well-being by monitoring adverse events and conducting periodic reviews of device performance. Additionally, reimbursement policies play a crucial role in market access, with government healthcare systems determining coverage and pricing to facilitate patient access to these essential medical devices. Overall, government policies in the Global Pancreatic and Biliary Stents Market are essential for maintaining industry integrity and promoting public health.
The Global Pancreatic and Biliary Stents Market is expected to witness significant growth in the coming years due to the rising prevalence of pancreatic and biliary disorders, such as pancreatitis, bile duct stones, and pancreatic cancer. Technological advancements in stent design and materials, along with increasing adoption of minimally invasive procedures, are driving market growth. The aging population and lifestyle factors contributing to the increasing incidence of these diseases further propel market expansion. Additionally, the growing awareness among patients and healthcare professionals about the benefits of stent placement for managing these conditions is expected to fuel market demand. However, challenges such as the high cost of stent procedures and complications associated with stent placement may hinder market growth to some extent. Overall, the Global Pancreatic and Biliary Stents Market is poised for steady growth in the foreseeable future.
In the Global Pancreatic and Biliary Stents Market, Asia is expected to witness significant growth due to the rising prevalence of pancreatic and biliary diseases, increasing healthcare expenditure, and growing awareness about advanced medical treatments. North America is projected to dominate the market, driven by the presence of well-established healthcare infrastructure, high adoption of advanced medical technologies, and a large patient pool. In Europe, the market is anticipated to grow steadily, supported by the increasing geriatric population prone to pancreatic and biliary disorders. The Middle East and Africa region is likely to experience moderate growth due to improving healthcare facilities and rising investments in healthcare infrastructure. Latin America is also expected to witness growth with the increasing focus on improving healthcare services and rising demand for minimally invasive procedures in the region.
Global Pancreatic and Biliary Stents Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pancreatic and Biliary Stents Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pancreatic and Biliary Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pancreatic and Biliary Stents Market - Industry Life Cycle |
3.4 Global Pancreatic and Biliary Stents Market - Porter's Five Forces |
3.5 Global Pancreatic and Biliary Stents Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pancreatic and Biliary Stents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Pancreatic and Biliary Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Pancreatic and Biliary Stents Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Global Pancreatic and Biliary Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pancreatic and Biliary Stents Market Trends |
6 Global Pancreatic and Biliary Stents Market, 2021 - 2031 |
6.1 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Plastic Stents, 2021 - 2031 |
6.1.3 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Metal Stents, 2021 - 2031 |
6.2 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Benign Biliary structures, 2021 - 2031 |
6.2.3 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Biliary Leaks, 2021 - 2031 |
6.2.4 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Pancreatic Cancer, 2021 - 2031 |
6.2.5 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Other Applications, 2021 - 2031 |
6.3 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.4 Global Pancreatic and Biliary Stents Market, Revenues & Volume, By Other End-Users, 2021 - 2031 |
7 North America Pancreatic and Biliary Stents Market, Overview & Analysis |
7.1 North America Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Latin America (LATAM) Pancreatic and Biliary Stents Market, Overview & Analysis |
8.1 Latin America (LATAM) Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9 Asia Pancreatic and Biliary Stents Market, Overview & Analysis |
9.1 Asia Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10 Africa Pancreatic and Biliary Stents Market, Overview & Analysis |
10.1 Africa Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11 Europe Pancreatic and Biliary Stents Market, Overview & Analysis |
11.1 Europe Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12 Middle East Pancreatic and Biliary Stents Market, Overview & Analysis |
12.1 Middle East Pancreatic and Biliary Stents Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pancreatic and Biliary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pancreatic and Biliary Stents Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pancreatic and Biliary Stents Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Pancreatic and Biliary Stents Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Pancreatic and Biliary Stents Market, Revenues & Volume, By End-Users, 2021 - 2031 |
13 Global Pancreatic and Biliary Stents Market Key Performance Indicators |
14 Global Pancreatic and Biliary Stents Market - Export/Import By Countries Assessment |
15 Global Pancreatic and Biliary Stents Market - Opportunity Assessment |
15.1 Global Pancreatic and Biliary Stents Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pancreatic and Biliary Stents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Pancreatic and Biliary Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Pancreatic and Biliary Stents Market Opportunity Assessment, By End-Users, 2021 & 2031F |
16 Global Pancreatic and Biliary Stents Market - Competitive Landscape |
16.1 Global Pancreatic and Biliary Stents Market Revenue Share, By Companies, 2024 |
16.2 Global Pancreatic and Biliary Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |